The CINP Executive Committee for the 33rd CINP World Congress of Neuropsychopharmacology (CINP 2022) is inviting the submission of abstracts. Please read the details below carefully before submitting an abstract.
Oral Presentation (A small number of abstracts will be selected as a 15+3 min oral presentations in a symposium on the topic in question. If you are not comfortable providing an oral presentation, please only select poster presentation during submission.)
Poster Presentation (abstracts not selected for oral presentation will be provided a poster presentation)
The CINP International Scientific Programme Committee welcomes abstracts that link the latest, and ground-breaking, preclinical developments with the clinical research on a given topic. Through the free and open exchange of ideas, CINP supports a strong focus on new approaches to the development and assessment of CNS pharmaceuticals by researchers working in both academia and industry. Please find below the list of topics: